Evidence map›Paper›PMID 40715155›Full record

ArticleNature communications2025

SMCHD1 maintains heterochromatin, genome compartments and epigenome landscape in human myoblasts.

Zhijun Huang, Wei Cui, Ishara Ratnayake, Kristin L Gallik, Lorna Cohen, Rabi Tawil, Gerd P Pfeifer

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Professor Emma Whitelaw, a pioneer of epigenetic inheritance.Frontiers in epigenetics and epigenomics · 2025
    Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Zhijun HuangDepartment of Epigenetics, Van Andel Institute, Grand Rapids, Michigan, USA.
Wei CuiDepartment of Epigenetics, Van Andel Institute, Grand Rapids, Michigan, USA.
Ishara RatnayakeCryo-EM Core, Van Andel Institute, Grand Rapids, Michigan, USA.
Kristin L GallikOptical Imaging Core, Van Andel Institute, Grand Rapids, Michigan, USA.
Lorna CohenOptical Imaging Core, Van Andel Institute, Grand Rapids, Michigan, USA.ORCID http://orcid.org/0009-0005-4450-1629
Rabi TawilDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Gerd P PfeiferDepartment of Epigenetics, Van Andel Institute, Grand Rapids, Michigan, USA. gerd.pfeifer@vai.org.ORCID http://orcid.org/0000-0002-5080-9604

Funding

5-methylcytosine oxidation in development and diseaseR01AR079174 · NIAMS · VAN ANDEL RESEARCH INSTITUTE · PI PFEIFER, GERD P · 2021 to 2025
$2.1M
NIAMS NIH HHS R01 AR079174U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR079174
6 · The paper itself

Abstract

Mammalian genomes are subdivided into euchromatic A compartments that contain mostly active chromatin, and inactive, heterochromatic B compartments. However, it is not well understood how A and B genome compartments are established and maintained. Here we study SMCHD1, an SMC-like protein best known for its role in X chromosome inactivation, in human male myoblasts. SMCHD1 colocalizes with Lamin B1 and the heterochromatin mark H3K9me3. Loss of SMCHD1 leads to extensive heterochromatin and Lamin B1 depletion at the nuclear lamina, acquisition of active chromatin states and increased DNA methylation along chromosomes. In absence of SMCHD1, long range intra-chromosomal contacts between B compartments are lost while many new TADs and loops are formed. Inactivation of SMCHD1 promotes numerous B to A compartment transitions accompanied by activation of silenced genes. The data suggests that SMCHD1 functions as an anchor for heterochromatin domains at the nuclear lamina ensuring that these domains are poorly accessible to DNA methyltransferases and to epigenome modification enzymes that typically operate in active chromatin. Thus, the properties of SMCHD1 in heterochromatin maintenance extend well beyond its role in X chromosome inactivation.

Indexed as

Chromosomal Proteins, Non-HistoneEpigenomeGenome, HumanHeterochromatinMyoblastsCell LineDNA MethylationHistonesHumansLamin Type BMaleNuclear LaminaX Chromosome InactivationChromosomal Proteins, Non-HistoneHeterochromatinHistonesLamin Type BSMCHD1 protein, human

Identifiers

PMID40715155
PMCPMC12297321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.